EGFR and neoplasm: Furthermore, the oncogenic contexts were qualitatively different from each other: loss of tumor suppressors generally led to increased rates of tumor initiation and growth in the KRAS backgrounds, had more muted effects in the BRAF context, and had variable effects in the EGFR context.